Skip to main content
Premium Trial:

Request an Annual Quote

'Superbug' Molecular Test From Mobidiag Gets CE Mark

NEW YORK (GenomeWeb) — Finnish diagnostics firm Mobidiag said today that it received CE-IVD marking for its Novodiag CarbaR+ test for carbapenemase-producing enterobacteriaceae (CPE), a bacteria resistant to carbapenem antibiotics.

The multiplex qPCR- and microarray-based test detects CPE and associated resistance markers, as well as a plasmid-mediated resistance for colistin, a last-resort antibiotic for many infections. It runs on the company's automated Novodiag system and produces results within 80 minutes.

Mobidiag currently offers two other CE-marked antibiotic resistance screening tests including CarbaR+VRE and CarbaR+MCR, which run on the firm's Amplidiag multiplex system.

"With our Amplidiag and Novodiag tests, we offer comprehensive diagnostic solutions to a wide range of infectious diseases in both centralized and decentralized laboratories, regardless of their size and patient volumes," Mobidiag CEO Tuomas Tenkanen said in a statement.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.